New Ono Chief Eager to Go Solo in US, Europe; BTK Med 1st Shield against Opdivo Patent Cliff

Ono President Toichi Takino Bracing for the patent expiry of its top-seller Opdivo (nivolumab), Ono Pharmaceutical is set to make aggressive efforts to build an independent development and marketing system in the US and Europe under the stewardship of its...read more